In: Pediatric Nephrology, 2015, vol. 30, no. 3, p. 503-513
|
In: Journal of Inherited Metabolic Disease, 2015, vol. 38, no. 5, p. 863-872
|
In: European Journal of Epidemiology, 2015, vol. 30, no. 12, p. 1263-1275
|
In: Sleep, 2016, vol. 39, no. 4, p. 945-953
|
In: Journal of Perinatal Medicine, 2017, vol. 45, no. 5, p. 613-617
|
In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 11, p. 3205-3212
|
In: Journal of Clinical Microbiology, 2020, p. -
A series of clinical NDM-5-producing E. coli isolates obtained from two surveillance networks of carbapenem-producing Enterobacterales from 2018-2019, namely Switzerland (NARA) and Germany (SurvCARE), were analyzed. The 33 NDM-5- producing E. coli isolates were highly resistant to β-lactams including the novel ß- lactam/ß-lactamase inhibitor combinations (ceftazidime/avibactam, ...
|
In: BMJ Open, 2018, vol. 8, no. 12, p. e023824
Objectives To estimate the incidence and epidemiology of catheter-related bloodstream infections (CRBSIs) on a national scale by using prospective epidemiological data from the Swiss Antibiotic Resistance Surveillance System (ANRESIS). Design Observational study. Setting National surveillance from 2008 to 2015 of acute hospitals in Switzerland. Participants We included acute Swiss hospitals...
|
In: Journal of Clinical Microbiology, 2019, vol. 57, no. 1, p. e01531-18
The rapid fosfomycin/Escherichia coli NP test was developed to detect fosfomycin resistance in E. coli isolates. The test is based on glucose metabolization and the detection of bacterial growth in the presence of fosfomycin at 40 µg/ml. Bacterial growth is visually detectable by an orange-to-yellow color change of red phenol, a pH indicator. A total of 100 E. coli isolates, among which 22...
|
In: Pediatric Nephrology, 2013, vol. 28, no. 7, p. 1141-1144
|